Arteaus Raises $18 Mln from Atlas Venture, OrbiMed Advisors
Arteaus Therapeutics said Wednesday that it raised $18 million in financing from Atlas Venture and OrbiMed Advisors. Arteaus Therapeutics, of Durham, N.C., is developing an antibody that is used to prevent migraine headaches.
19 October 2011•4 mins read
